NexgenRX Inc. (NXG) — Cash Flow Reinvestment Rate
NexgenRX Inc. (NXG) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CA$55.65K (capex CA$18.07K plus investments CA$-37.58K) from operating cash flow of CA$880.82K. See NXG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NexgenRX Inc. Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for NexgenRX Inc. across 8 annual periods. For the full cash flow conversion analysis, see NexgenRX Inc. (NXG) cash flow conversion.
Annual Cash Flow Reinvestment Rate for NexgenRX Inc. (2013–2024)
Year-by-year capital reinvestment analysis for NexgenRX Inc.. See NXG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CA$498.33K | CA$1.15 Million | CA$317.69K | ▲ +122.8% |
| 2023 | 0.19x | CA$248.41K | CA$1.28 Million | CA$248.41K | ▼ -76.8% |
| 2022 | 0.84x | CA$895.42K | CA$1.07 Million | CA$388.81K | ▲ +114.7% |
| 2021 | 0.39x | CA$1.50 Million | CA$3.82 Million | CA$126.55K | ▼ -13.4% |
| 2020 | 0.45x | CA$1.20 Million | CA$2.65 Million | CA$120.74K | ▼ -53.1% |
| 2019 | 0.96x | CA$1.01 Million | CA$1.05 Million | CA$50.78K | ▼ -33.4% |
| 2016 | 1.45x | CA$710.00K | CA$490.96K | CA$355.00K | ▲ +2269.5% |
| 2013 | 0.06x | CA$47.24K | CA$774.08K | CA$47.24K | — |